SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-113222
Filing Date
2022-11-01
Accepted
2022-11-01 09:09:29
Documents
14
Period of Report
2022-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229385d1_8k.htm   iXBRL 8-K 25085
2 EXHIBIT 99.1 tm2229385d1_ex99-1.htm EX-99.1 10090
6 GRAPHIC tm2229385d1_ex99-1img001.jpg GRAPHIC 3986
  Complete submission text file 0001104659-22-113222.txt   215630

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imgn-20221026.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20221026_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20221026_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2229385d1_8k_htm.xml XML 3464
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 221348683
SIC: 2834 Pharmaceutical Preparations